Human telomerase activity regulation A Wojtyla, M Gladych, B Rubis Molecular biology reports 38, 3339-3349, 2011 | 129 | 2011 |
Vitamin C as a Modulator of the Response to Cancer Therapy W Blaszczak, W Barczak, J Masternak, P Kopczyński, A Zhitkovich, ... Molecules 24 (3), 453, 2019 | 100 | 2019 |
Telomerase and drug resistance in cancer N Lipinska, A Romaniuk, A Paszel-Jaworska, E Toton, P Kopczynski, ... Cellular and Molecular Life Sciences 74, 4121-4132, 2017 | 86 | 2017 |
Universal real-time PCR-based assay for lentiviral titration W Barczak, W Suchorska, B Rubiś, K Kulcenty Molecular biotechnology 57, 195-200, 2015 | 82 | 2015 |
Telomere length: how the length makes a difference M Lulkiewicz, J Bajsert, P Kopczynski, W Barczak, B Rubis Molecular Biology Reports 47, 7181-7188, 2020 | 77 | 2020 |
Human telomerase expression regulation M Gladych, A Wojtyla, B Rubis Biochemistry and cell biology 89 (4), 359-376, 2011 | 75 | 2011 |
Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms J Mikuła-Pietrasik, A Kuczmarska, B Rubiś, V Filas, M Murias, P Zieliński, ... Free Radical Biology and Medicine 52 (11-12), 2234-2245, 2012 | 71 | 2012 |
Beneficial or harmful influence of phytosterols on human cells? B Rubis, A Paszel, M Kaczmarek, M Rudzinska, H Jelen, M Rybczynska British Journal of Nutrition 100 (6), 1183-1191, 2008 | 70 | 2008 |
The non-canonical functions of telomerase: to turn off or not to turn off A Romaniuk, A Paszel-Jaworska, E Totoń, N Lisiak, H Hołysz, A Królak, ... Molecular biology reports 46, 1401-1411, 2019 | 69 | 2019 |
Telomerase as a useful target in cancer fighting—the breast cancer case H Holysz, N Lipinska, A Paszel-Jaworska, B Rubis Tumor biology 34, 1371-1380, 2013 | 68 | 2013 |
Bystander senescence in human peritoneal mesothelium and fibroblasts is related to thrombospondin-1-dependent activation of transforming growth factor-β1 J Mikuła-Pietrasik, P Sosińska, J Janus, B Rubiś, M Brewińska-Olchowik, ... The international journal of biochemistry & cell biology 45 (9), 2087-2096, 2013 | 45 | 2013 |
Impact of common ABCB 1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites M Karaźniewicz‐Łada, D Danielak, B Rubiś, P Burchardt, A Komosa, ... Journal of clinical pharmacy and therapeutics 40 (2), 226-231, 2015 | 41 | 2015 |
Accumulation of environmental estrogens in adipose tissue of breast cancer patients M Ociepa-Zawal, B Rubis, D Wawrzynczak, R Wachowiak, WH Trzeciak Journal of Environmental Science and Health, Part A 45 (3), 305-312, 2010 | 40 | 2010 |
Study of ABCB1 polymorphism frequency in breast cancer patients from Poland B Rubiś, H Hołysz, W Barczak, R Gryczka, M Łaciński, P Jagielski, ... Pharmacological Reports 64 (6), 1560-1566, 2012 | 37 | 2012 |
Telomerase inhibitor TMPyP4 alters adhesion and migration of breast-cancer cells MCF7 and MDA-MB-231 N Konieczna, A Romaniuk-Drapała, N Lisiak, E Totoń, A Paszel-Jaworska, ... International Journal of Molecular Sciences 20 (11), 2670, 2019 | 34 | 2019 |
Polymorphism of the porcine leptin gene promoter and analysis of its association with gene expression and fatness traits M Stachowiak, M Mackowski, Z Madeja, M Szydlowski, A Buszka, ... Biochemical Genetics 45, 245-253, 2007 | 34 | 2007 |
The effect of indole-3-carbinol on the expression of CYP1A1, CYP1B1 and AhR genes and proliferation of MCF-7 cells M Ociepa-Zawal, B Rubiś, M Łaciński, W Trzeciak Acta Biochimica Polonica 54 (1), 113-117, 2007 | 33 | 2007 |
DAT1 methylation changes in alcohol-dependent individuals vs. controls A Jasiewicz, B Rubiś, J Samochowiec, I Małecka, A Suchanecka, ... Journal of Psychiatric Research 64, 130-133, 2015 | 32 | 2015 |
Phytosterols in physiological concentrations target multidrug resistant cancer cells B Rubis, A Polrolniczak, H Knula, O Potapinska, M Kaczmarek, ... Medicinal Chemistry 6 (4), 184-190, 2010 | 32 | 2010 |
The influence of genetic polymorphism of Cyp2c19 isoenzyme on the pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases M Karaźniewicz‐Łada, D Danielak, B Rubiś, P Burchardt, G Oszkinis, ... The Journal of Clinical Pharmacology 54 (8), 874-880, 2014 | 30 | 2014 |